Table 4. Baseline laboratory parameters - Quartiles.
n | Median survival [months] | 95%-CI | p-value | |
AFP | overall <0.0001* | |||
¼ | 97 | 29.7 | 19.6–38.8 | ¼ vs. ½: 0.777 |
½ | 97 | 28.4 | 21.3–38.2 | ½ vs. ¾: 0.001* |
¾ | 97 | 14.4 | 10.0–17.2 | ¾ vs. 1: 0.017* |
1 | 97 | 8.6 | 6.0–12.7 | |
Bilirubin | overall<0.0001* | |||
¼ | 98 | 28.8 | 22.5–34.0 | ¼ vs. ½: 0.214 |
½ | 109 | 18.9 | 15.6–28.4 | ½ vs. ¾: 0.55 |
¾ | 98 | 17.2 | 13.9–22.9 | ¾ vs. 1: 0.004* |
1 | 99 | 9.1 | 5.7–11.6 | |
Quick | overall 0.0215* | |||
¼ | 117 | 14.0 | 9.8–23.1 | ¼ vs. ½: 0.195 |
½ | 91 | 14.1 | 9.8–16.9 | ½ vs. ¾: 0.021* |
¾ | 98 | 25.3 | 15.2–32.7 | ¾ vs. 1: 0.371 |
1 | 96 | 23.4 | 16.8–30.8 | |
Albumin | overall <0.0001* | |||
¼ | 88 | 9.2 | 6.2–14.1 | ¼ vs. ½: 0.37 |
½ | 93 | 13.5 | 10.5–18.3 | ½ vs. ¾: 0.133 |
¾ | 106 | 22.2 | 14.4–28.6 | ¾ vs. 1: 0.025* |
1 | 91 | 31.4 | 21.1–38.2 | |
AP | overall <0.0001* | |||
¼ | 85 | 32,7 | 26,8–38,8 | ¼ vs. ½:0,150 |
½ | 85 | 27,6 | 21,7–48,1 | ½ vs. ¾: 0,030* |
¾ | 86 | 18,1 | 13,5–25,2 | ¾ vs. 1: <0,0001* |
1 | 85 | 6,4 | 4,5–9,8 |
(* = Statistically significant).